Preop and postop imaging vital for phakic IOLs

Article

Preop and postop imaging and endothelial cell counts are vital to check the position and performance of a phakic IOLs, Dr David Hardten told colleagues.

Preop and postop imaging and endothelial cell counts are vital to check the position and performance of a phakic IOLs, Dr David Hardten told colleagues.

"Why do I use phakic IOLs? Well, it is a very good technique to correct very large errors while retaining accommodation, in both myopia as well as hyperopia," he said.

In general, as was shown in the FDA clinical trial, he said, the results with just minimal imaging, spectral microscopy and central anterior chamber depth, were actually quite good in respect of safety and the effects of the implant, both in clinical trials where phakic IOLs were iris fixated as well anterior chamber implants.

But complications do occur, and imaging can help to minimise the risk of them happening, "Phakic IOLs require the usual refractive work-up including refraction and others," said Dr Hardten. "But you also need the anterior chamber depth, and you should look for it at both the periphery as well as the centre."

Dr Hardten showed the audience how ultrasound with the A-Scan, optics with the Orbscan (Bausch & Lomb) or Pentacam (Oculus), or OCT could provide that information. Other key metrics are the angle-to-angle and sulcus-to-sulcus measurements. Surgeons can use ultrasound, optical or OCT to obtain these figures.

Dr Hardten noted that postoperative imaging was very important too. "Analyse clearance between IOL and endothelium, and between the IOL and the crystalline lens. You also need to check the IOL position in relation to the ciliary sulcus and finally, you must continue with your cell counts."

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.